Dianne Alewood

Title: Dianne Alewood: Innovator in Conotoxin Peptides

Introduction

Dianne Alewood is a prominent inventor based in Pullenvale, Australia. She has made significant contributions to the field of biochemistry, particularly in the development of conotoxin peptides. With a total of two patents to her name, her work has implications for various medical conditions.

Latest Patents

Dianne Alewood's latest patents include innovative peptides that have potential therapeutic applications. One of her notable inventions is a synthetic or recombinant χ-conotoxin peptide, which comprises a specific sequence of amino acids. This peptide is designed for the prophylaxis or treatment of conditions such as pain, inflammation, incontinence, cardiovascular issues, and mood disorders. Another significant patent involves Type II chi-conotoxin peptides, which act as noradrenaline transporter inhibitors. These peptides are characterized by their ability to inhibit neuronal amine transporters, showcasing Dianne's expertise in peptide design and synthesis.

Career Highlights

Throughout her career, Dianne Alewood has been associated with Xenome Limited, where she has furthered her research and development efforts. Her work has not only advanced scientific understanding but also opened new avenues for pharmaceutical applications. Dianne's contributions to the field have been recognized by her peers and the scientific community.

Collaborations

Dianne has collaborated with notable colleagues, including Richard James Lewis and Paul Francis Alewood. These partnerships have enriched her research and fostered innovation in the development of conotoxin peptides.

Conclusion

Dianne Alewood's work in the field of conotoxin peptides exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her significant role as an inventor. Dianne continues to inspire future generations of scientists and inventors through her contributions to biochemistry.